Showing results (71-80 of 92) with videos related to

Sort By:
Pageof 10
Proceedings of the National Academy of Sciences of the United States of America|November 9, 2006
Correlation between beta cell mass and glycemic control in type 1 diabetic recipients of islet cell graftBart Keymeulen, Pieter Gillard, Chantal Mathieu, et al.
Diabetologia|September 28, 2015
Relationship between glycaemic variability and hyperglycaemic clamp-derived functional variables in (impending) type 1 diabetesAnnelien Van Dalem, Simke Demeester, Eric V Balti, et al.
Cell Transplantation|October 13, 2016
Identification of Donor Origin and Condition of Transplanted Islets In Situ in the Liver of a Type 1 Diabetic RecipientCornelis R van der Torren, Jessica S Suwandi, DaHae Lee, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 4, 2021
Function and composition of pancreatic islet cell implants in omentum of type 1 diabetes patientsFreya Van Hulle, Kaat De Groot, Robert Hilbrands, et al.
Diabetes Research and Clinical Practice|December 17, 2013
Clinical and biological characteristics of diabetic patients under age 40 in Cameroon: relation to autoantibody status and comparison with Belgian patientsMilca Asanghanwa, Frans K Gorus, Ilse Weets, et al.
Blood|December 17, 2009
Transient Epstein-Barr virus reactivation in CD3 monoclonal antibody-treated patientsBart Keymeulen, Sophie Candon, Samira Fafi-Kremer, et al.
BMC Medicine|May 24, 2023
First-in-human, double-blind, randomized phase 1b study of peptide immunotherapy IMCY-0098 in new-onset type 1 diabetesJean Van Rampelbergh, Peter Achenbach, Richard David Leslie, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|May 28, 2021
US food and drug administration (FDA) panel endorses islet cell treatment for type 1 diabetes: A pyrrhic victory?Lorenzo Piemonti, Axel Andres, John Casey, et al.
Drugs in R&D|March 18, 2006
A dual PPAR alpha/gamma agonist increases adiponectin and improves plasma lipid profiles in healthy subjectsKatelijn Decochez, Ronda K Rippley, Jutta L Miller, et al.
Pageof 10